although the overall efficacy of prep in this study (44 %) is disappointing compared to projected estimates, the results demonstrate proof-of-principle and suggest that greater efficacy is possible with higher adherence levels.
The case-control analysis hints that taking the drug shortly before exposure might be more relevant to efficacy than overall adherence levels are.